Total trials
1,040
Active
120
Phase 3
42
Total enrollment
624,148
Pipeline matrix
Showing 20 of 20 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Bryophyllum | — | — | — | — | 2 | ||
| Supplemental oxygen therapy | — | — | — | — | — | 1 | |
| Oxygen | — | — | — | — | 5 | ||
| Temozolomide | — | — | — | — | — | 2 | |
| Ruxolitinib Topical Cream | — | — | — | — | — | 1 | |
| Propranolol | — | — | — | — | — | 1 | |
| ALUTARD SQ® Felis domesticus | — | — | — | — | — | 1 | |
| Pembrolizumab | — | — | — | — | — | 1 | |
| Tideglusib | — | — | — | — | — | 1 | |
| Vortioxetine | — | — | — | — | — | 1 | |
| 50% N2O plus 50% O2 | — | — | — | — | — | 1 | |
| Control Group | — | — | — | — | — | 1 | |
| Gabapentin | — | — | — | — | — | 1 | |
| Sulfasalazine | — | — | — | — | — | 1 | |
| Memantine | — | — | — | — | — | 1 | |
| Sevoflurane | — | — | 9 | ||||
| intrathecal nivolumab and intrathecal ipilimumab | — | — | — | — | — | 1 | |
| Intranasal ketamine hydrochloride | — | — | — | — | — | 1 | |
| Fecal Microbiota Transplantation | — | — | — | — | — | 1 | |
| ¹⁸F-florbetaben | — | — | — | — | — | 1 |
Next readouts
- 2025-12
- 2025-12
- 2025-12-01
- 2026-04-22
- 2026-04-30
- 2026-06
- 2026-07-31
- 2026-09-30
- 2027-02
- 2027-05-31
Top conditions
- Healthy31
- Pulmonary Hypertension24
- Stroke17
- High Altitude Pulmonary Hypertension16
- Chronic Obstructive Pulmonary Disease16
- Glaucoma14
- Spinal Cord Injury11
- Coronary Artery Disease10
Frequently asked questions about University of Zurich
- How many clinical trials does University of Zurich have on ClinicalTrials.gov?
- University of Zurich is listed as the lead sponsor on 1,040 clinical trials in ClinicalTrials.gov, 120 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Zurich's trials are in Phase 3?
- 42 of University of Zurich's trials are in Phase 3, spread across 20 active drug programs.
- What therapeutic areas does University of Zurich focus on?
- University of Zurich's most-studied conditions on ClinicalTrials.gov are Healthy, Pulmonary Hypertension, Stroke, High Altitude Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease.
- When are University of Zurich's next clinical trial readouts?
- University of Zurich has 10 upcoming primary-completion readouts tracked here; the soonest is “Effects of Intranasal Ketamine on Depression and Anxiety in Palliative Care Cancer Patients”, expected around 2025-12.